|
(Wireless-NewsWire.Com, May 15, 2017 ) According to Publisher, the Bio Chip Market accounted for $7.35 billion in 2015 and is expected to grow at a CAGR of 19.6% to reach $25.8 billion by 2022. Increasing number of applications in drug discovery euipments, high precision of diagnosis treatments, growing number of cancer treatments leads to the usage of personalized medicine and high advancements in technology are some of the factors driving the market growth. However, unclear guiding principles, lack of awareness of biochips among rural communities and high cost of products are the restraints hampering the market growth during the forecast period. Considerable growth prediction in emerging countries such as China and India act as a opportunity for the biochip market.
For more information @ http://www.reportsweb.com/biochips-global-market-outlook-2015-2022
DNA biochips segment is expected to witness the highest CAGR across the globe due to its growing applications in biotechnology and drug discovery. North America region is estimated to have largest share across globe, attributed to its factors such as growing aging population and growing incidence of diseases. On the other hand, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period.
Some of the key players in global Bio Chip market include Abbott Laboratories, Agilent TechnologiesInc., Perkinelmer, Inc., Fluidigm Corporation, Roche Diagnostics, Thermo Fisher Scientific Inc., Cepheid Inc., Bio-Rad Laboratories Inc., GE Healthcare, Illumina Inc., Affymetrix Inc., Beckman Coulter Inc., Life Technologies Corp, Roche, Life Technologies Corp and Biomerieux SA.
Products Covered:
-Micro array
-Lab-On-A-Chip microarray
-Protein Microarray
-Other Protein Microarray
-DNA Microarray
-Other Microarray Types
-Tissue Biochips
-Carbohydrate Biochips
-Microfluidics
-Analysis Software
-Biochip instruments
-Biochip reagents
End Users Covered:
-Academic & Research Institute
-Biotechnology and Pharmaceutical Companies
-Hospitals and Diagnostics Centres
-Other End Users
Applications Covered:
-Diagnostic Applications
-Immune disease diagnostic
-Neurological diagnostic
-Cardiac diagnostic
-Other Applications
-Drug Discovery
-Structural Biology
-Lead Optimization
-Preclinical and Clinical Trial
-Process R&D
-Genomics
-Proteomics
-Other Applications
Functions Covered:
-Micro-RNA
-Gene Expression
-Epigenetic
-Genotyping
-Sequence Capture
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322771/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
11 Company Profiling
11.1 Abbott Laboratories
11.2 Agilent Technologies, Inc.
11.3 Perkinelmer, Inc.
11.4 Fluidigm Corporation
11.5 Roche Diagnostics
11.6 Thermo Fisher Scientific, Inc.
11.7 Cepheid Inc.
11.8 Bio-Rad Laboratories Inc.
11.9 GE Healthcare
11.10 Illumina, Inc.
11.11 Affymetrix Inc
11.12 Beckman Coulter Inc
11.13 Life Technologies Corp
11.14 Biomerieux SA
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322771/buying
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
|
